Two directors at Spyre Therapeutics executed massive open-market sales totaling $401.66M in a 7-day window, with the largest single sell ($399.66M by Fairmount Funds Management) representing ~4.6% of the $8.7B market cap. This is a highly material cluster sale that dwarfs routine insider activity and signals a significant reduction in insider alignment, likely ahead of a catalyst or valuation peak.
Price Chart
Executive Summary
Two directors at Spyre Therapeutics executed massive open-market sales totaling $401.66M in a 7-day window, with the largest single sell ($399.66M by Fairmount Funds Management) representing ~4.6% of the $8.7B market cap. This is a highly material cluster sale that dwarfs routine insider activity and signals a significant reduction in insider alignment, likely ahead of a catalyst or valuation peak.
Key Financial Metrics
Key Facts
- Fairmount Funds Management LLC sold 4,684,781 shares at $85.31 for $399.66M on 2026-06-23
- Michael Thomas Henderson sold 20,000 shares at $100.00 for $2.00M on 2026-06-22
- Total cluster sale value: $401.66M, representing ~4.6% of $8.7B market cap
- Non-cash derivative conversions by Fairmount (16,667 and 666,680 shares at $0) preceded the sale
- Prior 30-day insider activity: 5 sells totaling $402.7M, making this cluster the dominant driver
- Analyst consensus is 96% bullish (22 Buy/1 Hold), creating a potential sentiment disconnect
Financial Impact
Insider sales of $401.66M represent ~4.6% of market cap, a highly material reduction in insider ownership
Risk Factors
- Insider sale of this magnitude often precedes negative catalysts or signals peak valuation
- Potential secondary offering or lockup expiration could further pressure shares
- Analyst consensus is overwhelmingly bullish, creating crowded positioning risk if sentiment shifts
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SYRE-1782266221792 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 28d ago | Insider Cluster | $88.98 $90.80 | ▼ −2.05% | ▼ −3.25% | $93.19 (−4.73%) |
Aug 11, 2026 7w ago | Insider Cluster | $102.74 $107.82 | ▼ −4.94% | ▼ −5.35% | $93.19 (+9.30%) |
Aug 6, 2026 8w ago | Insider Cluster | $103.42 $101.85 | ▲ +1.52% | ▲ +2.73% | $93.19 (+9.89%) |
Jul 3, 2026 13w ago | Insider Cluster | $86.63 $98.75 | ▲ +13.99% | ▲ +13.06% | $93.19 (+7.57%) |
Jun 27, 2026 13w ago | Insider Cluster | $90.16 $88.74 | ▲ +1.57% | ▲ +2.96% | $93.19 (−3.36%) |
Jun 26, 2026 14w ago | S-3ASR | $90.16 $88.74 | ▼ −1.57% | ▼ −2.96% | $93.19 (+3.36%) |
Jun 24, 2026 14w ago | Insider Cluster | $86.24 $88.89 | ▼ −3.07% | ▼ −1.37% | $93.19 (−8.06%) |
Jun 15, 2026 15w ago | 8-K | $83.58 $100.32 | ▲ +20.03% | ▲ +21.41% | $93.19 (+11.50%) |
Jun 12, 2026 16w ago | Institutional Cluster | $80.79 $88.34 | ▲ +9.35% | ▲ +8.67% | $93.19 (+15.35%) |
Jun 11, 2026 16w ago | Institutional Cluster | $80.77 $87.49 | ▲ +8.32% | ▲ +7.89% | $93.19 (+15.38%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access